Papilloedema from Dural Venous Sinus Compression by Meningiomas

Alexander J.P.W. Hartmann; Michelle W. Latting; Michael S. Lee; Mark L. Moster; Amit M. Saindane; Nancy J. Newman; Valérie Biousse

doi:10.1080/01658107.2018.1524499

Papilloedema from Dural Venous Sinus Compression by Meningiomas

Alexander J.P.W. Hartmann, Michelle W. Latting, Michael S. Lee, Mark L. Moster, Amit M. Saindane, Nancy J. Newman, Valérie Biousse

Ophthalmology & Visual Neurosciences

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Intracranial mass lesions may cause intracranial hypertension secondary to venous hypertension when they compress the dural venous sinuses (DVS) and may present with isolated papilloedema, mimicking idiopathic intracranial hypertension. We report a series of 16 patients with isolated papilloedema related to meningiomas compressing the DVS seen from 2012 to 2016 at three institutions. Correct diagnosis was delayed in 10/16 patients and treatment required a multidisciplinary approach, often with multiple sequential interventions, including combinations of acetazolamide, cerebrospinal fluid-shunt, optic nerve sheath fenestration, surgical resection of the meningioma, radiation therapy, and endovascular venous stenting. Two patients also received anticoagulation for venous thrombosis secondary to venous sinus compression.

Original language	English (US)
Pages (from-to)	171-179
Number of pages	9
Journal	Neuro-Ophthalmology
Volume	43
Issue number	3
DOIs	https://doi.org/10.1080/01658107.2018.1524499
State	Published - May 4 2019

Bibliographical note

Funding Information:
Valérie Biousse is a consultant for Gensight Biologics (France), received research support from the NIH/PHS (P30-EY006360), NIH (R01-NS089694) and Research to Prevent Blindness.

Funding Information:
Nancy J. Newman is a consultant for Gensight Biologics (France) and serves on the Data Safety Monitoring Board for Quark Pharmaceuticals (Israel) clinical trial, has provided expert testimony on the topic of optic disc oedema, and has received research support from NIH grants (R01-NS089694, P30-EY006360) and Research to Prevent Blindness Lew R. Wasserman Merit Award.

Keywords

Papilloedema
intracranial hypertension
meningiomas

Access

10.1080/01658107.2018.1524499

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619970

Fingerprint Dive into the research topics of 'Papilloedema from Dural Venous Sinus Compression by Meningiomas'. Together they form a unique fingerprint.

Cite this

@article{dfab2cc80d5b44a7bcfe571bf1c705ed,

title = "Papilloedema from Dural Venous Sinus Compression by Meningiomas",

abstract = "Intracranial mass lesions may cause intracranial hypertension secondary to venous hypertension when they compress the dural venous sinuses (DVS) and may present with isolated papilloedema, mimicking idiopathic intracranial hypertension. We report a series of 16 patients with isolated papilloedema related to meningiomas compressing the DVS seen from 2012 to 2016 at three institutions. Correct diagnosis was delayed in 10/16 patients and treatment required a multidisciplinary approach, often with multiple sequential interventions, including combinations of acetazolamide, cerebrospinal fluid-shunt, optic nerve sheath fenestration, surgical resection of the meningioma, radiation therapy, and endovascular venous stenting. Two patients also received anticoagulation for venous thrombosis secondary to venous sinus compression.",

keywords = "Papilloedema, intracranial hypertension, meningiomas",

author = "Hartmann, {Alexander J.P.W.} and Latting, {Michelle W.} and Lee, {Michael S.} and Moster, {Mark L.} and Saindane, {Amit M.} and Newman, {Nancy J.} and Val{\'e}rie Biousse",

note = "Funding Information: Val{\'e}rie Biousse is a consultant for Gensight Biologics (France), received research support from the NIH/PHS (P30-EY006360), NIH (R01-NS089694) and Research to Prevent Blindness. Funding Information: Nancy J. Newman is a consultant for Gensight Biologics (France) and serves on the Data Safety Monitoring Board for Quark Pharmaceuticals (Israel) clinical trial, has provided expert testimony on the topic of optic disc oedema, and has received research support from NIH grants (R01-NS089694, P30-EY006360) and Research to Prevent Blindness Lew R. Wasserman Merit Award.",

year = "2019",

month = may,

day = "4",

doi = "10.1080/01658107.2018.1524499",

language = "English (US)",

volume = "43",

pages = "171--179",

journal = "Neuro-Ophthalmology",

issn = "0165-8107",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Papilloedema from Dural Venous Sinus Compression by Meningiomas

AU - Hartmann, Alexander J.P.W.

AU - Latting, Michelle W.

AU - Lee, Michael S.

AU - Moster, Mark L.

AU - Saindane, Amit M.

AU - Newman, Nancy J.

AU - Biousse, Valérie

N1 - Funding Information: Valérie Biousse is a consultant for Gensight Biologics (France), received research support from the NIH/PHS (P30-EY006360), NIH (R01-NS089694) and Research to Prevent Blindness. Funding Information: Nancy J. Newman is a consultant for Gensight Biologics (France) and serves on the Data Safety Monitoring Board for Quark Pharmaceuticals (Israel) clinical trial, has provided expert testimony on the topic of optic disc oedema, and has received research support from NIH grants (R01-NS089694, P30-EY006360) and Research to Prevent Blindness Lew R. Wasserman Merit Award.

PY - 2019/5/4

Y1 - 2019/5/4

N2 - Intracranial mass lesions may cause intracranial hypertension secondary to venous hypertension when they compress the dural venous sinuses (DVS) and may present with isolated papilloedema, mimicking idiopathic intracranial hypertension. We report a series of 16 patients with isolated papilloedema related to meningiomas compressing the DVS seen from 2012 to 2016 at three institutions. Correct diagnosis was delayed in 10/16 patients and treatment required a multidisciplinary approach, often with multiple sequential interventions, including combinations of acetazolamide, cerebrospinal fluid-shunt, optic nerve sheath fenestration, surgical resection of the meningioma, radiation therapy, and endovascular venous stenting. Two patients also received anticoagulation for venous thrombosis secondary to venous sinus compression.

AB - Intracranial mass lesions may cause intracranial hypertension secondary to venous hypertension when they compress the dural venous sinuses (DVS) and may present with isolated papilloedema, mimicking idiopathic intracranial hypertension. We report a series of 16 patients with isolated papilloedema related to meningiomas compressing the DVS seen from 2012 to 2016 at three institutions. Correct diagnosis was delayed in 10/16 patients and treatment required a multidisciplinary approach, often with multiple sequential interventions, including combinations of acetazolamide, cerebrospinal fluid-shunt, optic nerve sheath fenestration, surgical resection of the meningioma, radiation therapy, and endovascular venous stenting. Two patients also received anticoagulation for venous thrombosis secondary to venous sinus compression.

KW - Papilloedema

KW - intracranial hypertension

KW - meningiomas

UR - http://www.scopus.com/inward/record.url?scp=85055289095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055289095&partnerID=8YFLogxK

U2 - 10.1080/01658107.2018.1524499

DO - 10.1080/01658107.2018.1524499

M3 - Article

C2 - 31312241

AN - SCOPUS:85055289095

VL - 43

SP - 171

EP - 179

JO - Neuro-Ophthalmology

JF - Neuro-Ophthalmology

SN - 0165-8107

IS - 3

ER -

Papilloedema from Dural Venous Sinus Compression by Meningiomas

Abstract

Bibliographical note

Keywords

Access

Other files and links

Cite this